STONERIDGE INVESTMENT PARTNERS LLC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 140 filers reported holding NEKTAR THERAPEUTICS in Q1 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
STONERIDGE INVESTMENT PARTNERS LLC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q2 2020$635,000
+6.7%
27,439
-17.7%
0.27%
-0.4%
Q1 2020$595,000
-17.4%
33,3390.0%0.27%
+9.8%
Q4 2019$720,000
+15.8%
33,339
-2.3%
0.24%
+7.0%
Q3 2019$622,000
-51.9%
34,139
-6.2%
0.23%
-50.3%
Q2 2019$1,294,000
+399.6%
36,377
+236.7%
0.46%
+1019.5%
Q3 2017$259,000
-74.9%
10,804
-79.6%
0.04%
-73.4%
Q2 2017$1,033,000
+77.8%
52,856
+11.7%
0.15%
+94.9%
Q4 2016$581,000
-47.6%
47,337
-51.5%
0.08%
-62.9%
Q4 2013$1,108,000
+33.3%
97,584
+22.7%
0.21%
+17.0%
Q3 2013$831,000
+13.5%
79,548
+25.6%
0.18%
+6.4%
Q2 2013$732,00063,3480.17%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2014
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders